Jake Hays is an associate in the firm’s Business Law Department and a member of its Technology and Life Sciences groups. His practice focuses on general corporate representation, venture capital financings, mergers and acquisitions, and public offerings. He counsels emerging growth companies at all stages of maturity, including formation, initial funding, expansion, and exit. Mr. Hays represents both private and public companies across a broad range of industries, including biotechnology and diagnostics, AI, Edtech, Fintech, Medtech, e-commerce, retail and consumer products, media and entertainment, consumer and enterprise software, cannabis, and alternative energy and other clean technologies.





Representative Matters



Venture Financings
  • Sionna Therapeutics in its $111 million Series B financing
  • Vedere Bio II in its $77 million Series A financing  
  • Triplet Therapeutics in its $49 million Series A financing
  • Quentis Therapeutics in its $48 million Series A financing
  • Cadent Therapeutics in its $40 million Series B financing
  • Hodinkee in its $40 million Series B financing
  • LeafLink in its $35 million Series B financing
  • Alto Solutions in its $17 million Series A financing and $40 million Series B financing
  • Noodle Partners in its $16 million Series B financing and $50 million Series C financing
  • Bessemer Venture Partners’ investment in Papaya’s $50 million Series B financing
  • Two Sigma Ventures’ investment in Remote Technology’s $11 million Series Seed financing
  • Digital+ Partners’ investment in ChartIQ’s $17 million Series B financing
  • Batu Capital Investments’ investment in MJ Freeway’s $10 million Series C financing
Mergers and Acquisitions
  • LaSalle Hotel Properties in a $5.2 billion merger with Pebblebrook Hotel Trust
  • TripleLift in its $1.4 billion acquisition by Vista Equity Partners
  • Kensho Technologies in its $550 million acquisition by S&P Global
  • Lennar Corporation in the sale of its SunStreet solar platform to Sunnova Energy
  • Johnson & Johnson in the sale of its BabyCenter business to Everyday Health Group
  • TARA Biosystems in its acquisition by Valo Health
  • Plug Power in its $58 million acquisition of Giner ELX, Inc. 
  • Plug Power in its $65 million acquisition of United Hydrogen Group Inc.
  • Vedere Bio in its $280 million acquisition by Novartis
  • OncoImmune in its $425 million acquisition (plus undisclosed milestone payments) by Merck
Strategic Alliances and Collaborations
  • Arrakis in its research collaboration agreement with Amgen on the discovery and development of RNA degrader therapeutics, with an upfront of $75 million and up to several billion dollars in potential milestones and royalties
  • Amathus Therapeutics on its strategic collaboration with Merck to develop novel small molecule therapeutic candidates for neurodegenerative diseases, for an upfront payment and milestone payments associated with the successful development candidates in excess of $500 million per program
Public Offerings
  • SpringWorks Therapeutics, Inc. in its $186.3 million initial public offering
  • Cowen and Company and William Blair as underwriters in a $32.5 million follow-on offering for Ovid Therapeutics Inc.
  • Oppenheimer & Co. Inc. as underwriters in a $15.4 million follow-on public offering for BioLineRx, Inc.
  • Stifel, Nicolaus & Company as underwriters in a $11.5 million follow-on public offering for IRIDEX Corporation
Professional Activities

Mr. Hays serves as the New York Co-Chair of Goodwin’s Neighborhood Business Initiative (NBI), a program created to provide pro bono legal services to low-income entrepreneurs and small business owners in underserved communities.

Mr. Hays is a member of the Board of Directors of the scientific research institute PSE Healthy Energy (Physicians, Scientists & Engineers) and a member of the Board of Directors of Artists with Evidence, a nonprofit that commissions artists and scientists to collaborate, explore and exhibit art works.
Professional Experience
Prior to joining Goodwin, Mr. Hays served as the Director of the Environmental Health Program at PSE Healthy Energy and as a research associate at Weill Cornell Medicine.


While in law school, Mr. Hays served as the senior articles editor for the Fordham Environmental Law Review, for which he authored Feeling the Noise: Proposed Standards and Alternatives to Wind Energy Nuisance Litigation, 28 Fordham Envtl. L. Rev. 242 (2017). Mr. Hays was chosen as a Stein Scholar for his efforts in public service and received the Adele Monaco Memorial Award, the Archibald R. Murray Public Service Award and the Public Service Student Leadership Award.

In The News









J.D., 2017
Fordham University School of Law
(magna cum laude and Order of the Coif)
M.A., 2011
University of Montana
B.A., 2006
Connecticut College
(cum laude)



New York
Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.


Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
Recherche par Pratique